Hepatitis a surveillance and vaccine use in China from 1990 through 2007

Journal of Epidemiology

Volumn 19, Issue 4, 2009, Pages 189-195

  Cui, Fuqiang ^a   Hadler, Stephen C ^b   Zheng, Hui ^a   Wang, Fuzhen ^a   Zhenhua, Wu ^a   Yuansheng, Hu ^a   Gong, Xiaohong ^a   Chen, Yuansheng ^a   Liang, Xiaofeng ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b WHO representative ofce in China   (China)

Author keywords

Epidemiology; Hepatitis A; Surveillance; Vaccine

Indexed keywords

HEPATITIS A VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CHINA; DRUG UTILIZATION; EPIDEMIC; GEOGRAPHY; HEALTH SURVEY; HEPATITIS A; HUMAN; INCIDENCE; INFANT; NEWBORN; OCCUPATION; POPULATION DYNAMICS; PRESCHOOL CHILD; SEX DIFFERENCE; STATISTICS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CHINA; DISEASE OUTBREAKS; DRUG UTILIZATION; GEOGRAPHY; HEALTH TRANSITION; HEPATITIS A; HEPATITIS A VACCINES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; OCCUPATIONS; POPULATION SURVEILLANCE; SEX FACTORS;

EID: 68549104153     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.JE20080087     Document Type: Article

References (23)

1. WHO, Weekly Epidemiological Record. Hepatitis A vaccines, WHO position paper, 2000, 75, 37-44.
2. Hadler SC. Global impact of hepatitis A virus infection-Changing patterns. In Hollinger FB, Lemon SM, Margolis H (eds) Viral Hepatitis And Liver Disease. Williams and Wilkens, Baltimore, MD 1991.
3. Barzaga BN. Hepatitis A shifting epidemiology in South-east Asia and China. Vaccine. 2000;18 S1:S61-4.
4. Jacobsen KH, Koopman JS. The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns. Int J Epidemiol. 2005 Jun;34(3):600-9. Epub 2005 Apr 14.
5. Mausezahl D, Cheng F, Zhang SQ, Tanner M. Hepatitis A in a Chinese urban population: the spectrum of social and behavioral risk factors. Int J Epidemiol. 1996;25:1271-9.
6. Lopez E, Debbag R, Coudeville L, Baron-Papillon F, Armoni J. The cost-effectiveness of universal vaccination of children against hepatitis A in Argentina: results of a dynamic healtheconomic analysis. J Gastroenterol. 2007 Feb;42(2):152-60. Epub 2007 Mar 12.
7. Dagan R, Leventhal A, Anis E, Slater P, Ashur Y, Shouval D. Incidence of hepatitis A in Israel following universal immunization of toddlers. JAMA. 2005;294:202-10.
8. Wasley A, Samandari T, Bell B. Incidence of hepatitis A in the United States in the era of vaccination. JAMA. 2005;294:194-201.
9. Chodick G, Green MS, Heymann AD, Rosenmann L, Shalev V. The shifting epidemiology of hepatitis A following routine childhood immunization program in Israel. Prev Med. 2007 Nov;45(5):386-91. Epub 2007 May 21.
10. Cooksley WG. What did we learn from the Shanghai hepatitis A epidemic? J Viral Hepat. 2000 May;7 Suppl 1:1-3.
11. Shen YG, Gu XJ, Zhou JH. Protective effect of inactivated hepatitis A vaccine against the outbreak of hepatitis A in an open rural community. World J Gastroenterol. 2008;14(17):2771-5.
12. Zhang LJ, Wang XJ, Bai JM, Fang G, Liu LG, Zhang Y, et al. An outbreak of hepatitis A in recently vaccinated students from ice snacks made from contaminated well water. Epidemiol Infect. 2009 Mar;137(3):428-33. Epub 2009 Feb 9.
13. Barrimah E, Salem KA, Gabal MS. An outbreak of hepatitis A associated with treated waste water used for irrigation. J Egypt
14. Zheng H, Lu Y, Wang FZ, Cui FQ. Epidemiological Analysis on hepatitis A in China during 2004-2006 (English abstract). Chinese Journal of Vaccines and Immunization. 2007;13(4):336-40.
15. Wang XY, Xu ZY, Ma JC, von Seidlein L, Zhang Y, Hao ZY, et al. Long-term immunogenicity after single and booster dose of a live attenuated hepatitis A vaccine: results from 8-year follow-up. Vaccine. 2007;25(3):446-9. Epub 2006 Aug 17.
16. Mao JS, Chai SA, Xie RY, Chen NL, Jiang Q, Zhu XZ, et al. Further evaluation of the safety and protective efcacy of live attenuated hepatitis A vaccine (H2-strain) in humans. Vaccine. 1997;15(9):944-7.
17. Zhuang FC, Qian W, Mao ZA, Gong YP, Jiang Q, Jiang LM, et al. Persistent efcacy of live attenuated hepatitis A vaccine (H2-strain) after a mass vaccination program. Chin Med J (Engl). 2005;118(22):1851-6.
18. National Bureau of Statistical of China China Statistical Yearbook in 2007. China Statistic Press, Beijing, 2008.
19. Jiang WP, Chen JT, Wang X, Wang YL, Yan Liu Y, Chen WY, et al. Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive®): A double-blind, randomized and controlled trial. Vaccine. 2008;26(18):2297-301.
20. Wang ZS, Shepard DS, Zhu YC, Cash RA, Zhao RJ, Zhu ZX, et al. Reduction of enteric infectious disease in rural China by providing deep-well tap water. Bull World Health Organ. 1989;67(2):171-80.
21. Xu ZY. Decline in Risk of HAV in China, a Country with Booming Economy & Changing Life Style, Abstract, Global Hepatitis A conference, December 12, 2007, Miami, FL, USA. P47.
22. Averhoff F, Shapiro CN, Bell BP, Hyams I, Burd L, Deladisma A, et al. Control of hepatitis A through routine vaccination of children. JAMA. 2001;286(23):2968-73.
23. Dai ZC, Qi GM. Viral hepatitis in China: sero-epidemiological survey in Chinese population 1992-1995 (part one). Beijing: Scientic and Technical Documents Publishing House: 1999.